Skip to main content

VINCA ALKALOID TOXICITY

Tracking # 20-1056122

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

VINCA ALKALOIDS, WHICH BELONG TO A CLASS OF CELL CYCLE PHASE M SPECIFIC ANTI-TUBULIN AGENTS ARE ONE OF THE FIRST PLANT ALKALOIDS TO BE DEVELOPED FOR USE AS ANTI-CANCER AGENTS IN HUMANS. THIS ACTIVITY DESCRIBES THE INCIDENCE, ETIOLOGY, CLINICAL FEATURES, EXAMINATION FINDINGS, DIFFERENTIAL DIAGNOSIS, ASSESSMENT, AND MANAGEMENT OF SYSTEMIC EFFECTS OF VINCA ALKALOIDS, WITH AN EMPHASIS ON VINCRISTINE-INDUCED NEUROTOXICITY.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I